Quick Answer
Stemtech Corp reported Cash and Equivalents of $132.5 thousand for fiscal year 2022.
Stemtech Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $132.5K | -84.0% |
| 2021 | $828.2K | +522.4% |
| 2020 | $133.1K | +5885.8% |
| 2020 | $2.2K | +211.3% |
| 2019 | $714.00 | -91.3% |
| 2018 | $8.2K | -4.1% |
| 2017 | $8.6K | +133.4% |
| 2016 | $3.7K | +349.8% |
| 2015 | $819.00 | -95.5% |
| 2014 | $18.1K | -8.5% |
| 2013 | $19.8K | +1143.9% |
| 2012 | $1.6K | +10.5% |
| 2011 | $1.4K | — |
| 2009 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $343.3K | -32.8% | +159.1% |
| December 31, 2022 | $132.5K | -84.0% | -66.9% |
| June 30, 2022 | $399.7K | — | -21.8% |
| March 31, 2022 | $511.2K | — | -38.3% |
| December 31, 2021 | $828.2K | +522.4% | -48.2% |
| September 30, 2021 | $1.60M | +1372.4% | +324725.8% |
| May 31, 2021 | $492.00 | — | +80.9% |
| February 28, 2021 | $272.00 | — | -99.8% |
- Stemtech Corp showed a decrease of -84.0% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from Stemtech Corp’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: